SIGHT SCIENCES, INC. Current Liabilities
SIGHT SCIENCES, INC. (SGHT) had Current Liabilities of $20.50 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-05
- 2026-06-30: Liabilities, Current $20.50M.
- 2026-03-31: Liabilities, Current $18.16M.
- 2025-12-31: Liabilities, Current $11.03M.
- 2025-09-30: Liabilities, Current $11.83M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $20.50M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $18.16M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $11.03M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $11.83M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $11.94M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $12.12M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $15.47M 10-K · filed 2026-03-04 |
| 2024-09-30 | $13.80M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $13.29M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $11.69M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $12.25M 10-K · filed 2025-03-07 |
| 2023-09-30 | $14.33M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $14.05M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $15.14M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $17.82M 10-K · filed 2024-03-13 |
| 2022-09-30 | $17.39M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $14.20M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $12.00M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $13.50M 10-K · filed 2023-03-16 |
| 2021-09-30 | $10.31M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $12.06M 10-Q · filed 2021-08-12 |
| 2020-12-31 | $9.31M 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |